Daiichi Sankyo Inc.

Two Hilton Court
Parsippany
NJ
07054
USA
Phone: 
(973) 359-2600
http://www.dsi.com
Product Categories: Taxo=pharmaceuticals&Taxo=diagnostic_and_interventional_cardiology_daic

Related Articles

Cath Lab

Studies Show Effect of Prasugrel vs. Clopidogrel on Readmissions, Initial Hospitalization Costs in ACS-PCI Patients
Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
TRILOGY ACS Shows Prasugrel Not Superior to Clopidogrel in Medically Managed Non-STEMI Patients Without Revascularization
New Data and Recent Advances in Antiplatelet Agents
Prasugrel Significantly Reduces Cardiovascular Events Over Clopidogrel

Antiplatelet Therapy

Studies Show Effect of Prasugrel vs. Clopidogrel on Readmissions, Initial Hospitalization Costs in ACS-PCI Patients
Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
TRILOGY ACS Shows Prasugrel Not Superior to Clopidogrel in Medically Managed Non-STEMI Patients Without Revascularization
New Data and Recent Advances in Antiplatelet Agents
Prasugrel Significantly Reduces Cardiovascular Events Over Clopidogrel

Clinical Trial/Study

Studies Show Effect of Prasugrel vs. Clopidogrel on Readmissions, Initial Hospitalization Costs in ACS-PCI Patients
Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
TRILOGY ACS Shows Prasugrel Not Superior to Clopidogrel in Medically Managed Non-STEMI Patients Without Revascularization
Pan-European Stroke Prevention in Atrial Fibrillation Registry Enrolls First Patient
Drug Trial Started to Prevent, Treat Venous Thromboembolism

Pharmaceuticals

Studies Show Effect of Prasugrel vs. Clopidogrel on Readmissions, Initial Hospitalization Costs in ACS-PCI Patients
Low Clopidogrel Responsiveness Predicts Stent Thrombosis, Heart Attack
New Data and Recent Advances in Antiplatelet Agents
Prasugrel Significantly Reduces Cardiovascular Events Over Clopidogrel
Trial Begins for Stroke Prevention Drug in AF Patients
Three-in-One Blood Pressure Pill Approved in Germany
FDA Clears Three-In-One Drug for High Blood Pressure
Drug Trial Started to Prevent, Treat Venous Thromboembolism
Welchol Receives FDA Clearance to Lower LDL Cholesterol in Pediatric Patients

Platelet Function Monitors

New Data and Recent Advances in Antiplatelet Agents

EP Lab

Pan-European Stroke Prevention in Atrial Fibrillation Registry Enrolls First Patient

Stroke Treatment Devices

Trial Begins for Stroke Prevention Drug in AF Patients

Hypertension Therapies

Three-in-One Blood Pressure Pill Approved in Germany